We have investigated the polymorphism in intron 2 of the interleukin-1 receptor antagonist gene and identified two new alleles of the system. We have shown that the polymorphism is caused by the variable copy number of an 86-bp sequence, by using the polymerase chain reaction and primers immediately flanking the repeat region, and by direct sequencing. The repeat region contains three potential protein-binding sites and therefore the variable copy number may have functional significance.
Objective. We have previously described associations between an allele of the interleukin-1 receptor antagonist gene (ILlRN) and several inflammatory diseases. In this study we tested the ILlRN gene as a possible marker in patients with systemic lupus erythematosus (SLE).Methods. Eighty-one SLE patients and 261 ethnically matched control subjects were genotyped by polymerase chain reaction.Results. We found an increase in both frequency and carriage rate of ILlRN*2 in the SLE group. This association strengthened with extensive disease and particularly with the presence of photosensitivity and discoid skin lesions.Conclusion. We describe a novel association between ILlRN*2 and SLE. Carriage of the allele seems to influence severity rather than susceptibility to SLE. We postulate that the association of this polymorphism with disease severity is a widespread feature of common inflammatory and autoimmune diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.